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Background/aim: About 10%–15% of couples around the world suffer from infertility. Male infertility is responsible directly or
indirectly in ~60% of cases. A deficiency in semen is the most common cause of male infertility.
Materials and methods: The study included 180 male subjects aged 18–50 years with 26 fertile and 154 infertile. The infertile subjects
were further subdivided according to the WHO guidelines of semen analysis (2010) into different clinical groups. Sperm DNA damage
was estimated using a neutral comet assay. Plasma gonadotropin and testosterone levels were measured using a chemiluminescence
assay.
Results: The results of the study revealed no significant differences in semen volume, pH, and liquefaction time between the fertile and
all infertile groups. However, sperm concentration, sperm vitality, and sperm motility were significantly lower in all infertile groups
as compared to the fertile males. The morphological forms of the sperm and its DNA fragmentation varied significantly between the
fertile and infertile males. Reproductive hormone levels were observed to be significantly lower in the infertile than in the fertile males.
Conclusion: Sperm DNA fragmentation was higher in all of the infertile subjects as compared to the fertile ones. Reproductive hormone
levels varied significantly between the infertile patients and the fertile ones.
Key words: Male infertility, comet assay, DNA fragmentation, sperm concentration, sperm vitality, sperm morphology

1. Introduction
Infertility is the inability of a couple to conceive naturally
after one year of regular unprotected sexual intercourse.
Infertility is perceived as a social and public problem across
virtually all cultures and societies. It affects 13%–15% of the
reproductive-aged couples worldwide. The prevalence of
infertility varies widely from region to region, being higher
in developing countries, where there is a lack of resources for
investigation and treatment, than in developed countries (1).
Infertility is one of the most important and underappreciated
reproductive health problems in developing countries (2,3).
The inability to procreate is considered a personal tragedy
and a curse for couples, impacting the entire family and even
the local community (4).
Male infertility is the inability of a male partner to
achieve a pregnancy in a fertile female partner. Male
infertility is directly or indirectly responsible for 60% of
* Correspondence: mohsin.ibms@kmu.edu.pk

the cases involving the reproductive-aged couples with
fertility related issues (5–7). During ejaculation, semen is
produced from a concentrated suspension of spermatozoa
stored in the epididymis and mixed with fluid secretions of
the accessory sex glands. Semen has two major quantifiable
attributes. Firstly, the total number of spermatozoa, which
reflects sperm production by the testes and secondly, the
patency of the posttesticular duct system and total fluid
volume contributed by the various accessory glands, which
reveal the secretory activity of the glands. The nature of
the spermatozoa (vitality, motility, and morphology)
and the composition of the seminal fluid are important
parameters for proper sperm function (8). A deficiency
in semen, either quantitative or qualitative, is the most
common cause of male infertility. Semen analysis is the
single most important and fundamental initial laboratory
investigation for the assessment of male infertility (9).
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Clinical evaluation of the contribution of a male towards
the infertility of a couple is usually confined to measures
of total sperm count, sperm concentration, normal and
abnormal sperm forms, and motility. The predictive value
of these measurements is limited only to describing some
aspects of the function of the testis and sperm. They do not
address the integrity of the male genome contained in the
head of the sperm (6,10,11). The DNA integrity in sperm is
essential for the success of natural or assisted fertilization
as well as the normal development of the embryo, fetus,
and child. Moreover, DNA damage in sperm may carry
mutations into the next generation or result in male
infertility (12,13).
This cross sectional study was designed to determine
the semen quality of fertile and infertile Pakistani men,
to identify the relationship of sperm DNA integrity to
seminal parameters and reproductive hormonal levels in
the infertile men, and to make a comparison with those of
the fertile ones.
2. Materials and methods
The study included 180 male subjects aged 18–50
years. Among the 180 male subjects, 26 (14.45%) were
fertile (proven fathers) and 154 (85.55%) were infertile
(those whose marital duration was more than one year
and had failed to procreate during the last one year of
regular unprotected sexual intercourse). The infertile
subjects were further subdivided into 22 (12.22%) with
asthenozoospermia, 9 (5%) with asthenoteratozoospermia,
20 (11.12%) with azoospermia, 58 (32.22%) with
normozoospermia, 7 (03.88%) with oligozoospermia, 12
(06.66%) with oligoasthenozoospermia, and 26 (14.45%)
with oligoasthenoteratozoospermia. This division of
infertile subjects into different groups was based strictly
on the semen analysis according to the nomenclature
of the WHO Laboratory Manual for the Examination
and Processing of Human Semen (9). All subjects were
subjected to thorough clinical examination to exclude
those suffering from chronic health problems.
The study was approved by the Institutional Review
Board (IRB) and Advanced Studies and Research Board
(ASRB) of Khyber Medical University, Peshawar, Pakistan.
Written informed consent was obtained from the subjects
and participation in the study was voluntary. Fertile and
infertile subjects were recruited from the two private
clinics in Dera Ismail Khan, Pakistan.
2.1. Semen samples
The semen samples were collected by masturbation
into preweighed labeled containers at Bilal Clinical
Laboratory after a sexual abstinence of 3 days, were kept
at 37 °C during liquefaction, and were analyzed soon after
liquefaction according to WHO guidelines. The viscosity
of each sample was evaluated by introducing a glass rod
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into the sample and observing the length of the thread that
formed upon the withdrawal of the rod. Semen volume
was assessed by weighing the sample in the vessel in
which it was collected and subtracting the weight of the
empty container, assuming the semen density to be 1 g/
mL. Semen pH was measured with the help of pH paper
in the range of 6 to 10. Sperm motility was assessed using
10 µL of well-mixed semen placed on a clean glass slide,
covered with a 22 × 22 mm coverslip, and then examined
at a total magnification of 400×. The sperm were classified
as progressively motile, nonprogressively motile, and
immotile in order to record the proportion of motile
spermatozoa. For the assessment of sperm concentration,
the samples were diluted in a solution of 0.6 mol/L
NaHCO3 and 0.4% (v/v) formaldehyde in distilled water,
and subsequently assessed using an improved Neubauer
hemocytometer. Only complete sperms (sperms with tails)
were counted. Smears were prepared for morphological
evaluation, sperm vitality, and sperm DNA fragmentation.
Sperm morphology and sperm vitality smears were
stained with Spermac stain and VitalScreen, both
manufactured by FertiPro N.V. (Belgium). Approximately
200 spermatozoa in each replicate were evaluated. The
comet assay protocol was performed on all semen samples
according to the Enciso (14) method. Sperm cells were
diluted to a concentration of 10 × 106 spermatozoa/mL in
phosphate-buffered saline (PBS). Next, 25 μL of the cell
dilution was mixed at 37 °C with 50 μL of freshly prepared
1% low-melting point agarose (Sigma Aldrich, St Louis,
MO, USA) in distilled water. An aliquot of 15 μL of the
mixture was placed on a pretreated slide for gel adhesion
(1% low-melting point agarose), covered with cover slips,
and allowed to gel on a cold plate at 4 °C for 5 min. As soon
as the gel solidified, the cover slips were smoothly removed
and the slides were submerged sequentially in two lysing
solutions: lysing solution 1 [0.4 mol/L Tris–HCl, 0.8 mol/L
dithiothreitol (DTT), 1% sodium dodecyl sulfate (SDS),
pH 7.5] for 30 min, followed by lysing solution 2 (0.4 mol/L
Tris–HCl, 2 mol/L NaCl, 1% SDS, 0.05 mol/L EDTA, pH
7.5) for 30 min. Then slides were rinsed in TBE buffer (0.09
mol/L Tris–borate, 0.002 mol/L EDTA, pH 7.5) for 10 min,
transferred to an electrophoresis tank, and immersed in
fresh TBE electrophoresis buffer. Electrophoresis was
performed at 20 V (1 V/cm), 12 mA for 12.5 min. After
washing in 0.9% NaCl, the nucleoids were unwound in
an alkaline solution (0.03 mol/L NaOH, NaCl 1 mol/L)
for 2.5 min, transferred to an electrophoresis chamber,
and oriented 90° to the first electrophoresis. The second
electrophoresis was performed at 20 V (1 V/cm), 12 mA
for 4 min in 0.03 mol/L NaOH. Then the slides were rinsed
once in a neutralization buffer (0.4 mol/L Tris-HCl, pH
7.5) for 5 min, briefly washed in TBE buffer, dehydrated
in increasing concentrations of ethanol, and air dried. All
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comet assay samples were stained with DAPI (Invitrogen,
Eugene, OR, USA) and were evaluated using a fluorescence
microscope, counting at least 200 spermatozoa per sample.
The sperm cells were classified according to fragmented
and nonfragmented sperm (15).
2.2. Blood samples
Nonfasting venous blood samples were collected from the
subjects using disposable sterile syringes. The serum was
separated through centrifugation at 1600 × g and stored
at –80 °C for subsequent hormonal analysis. Follicle
stimulating hormone (FSH), luteinizing hormone (LH),
and testosterone were quantitatively determined using
chemiluminescence assay (CLIA) kits manufactured by
Monobind Inc. (USA). Assays were done according to the
manufacturer’s instructions.
2.3. Statistical analysis
Results were expressed as mean ± SD. The obtained
results were analyzed and compared by one-way analysis
of variance followed by a post-hoc Tukey test using SPSS
version 16 (SPSS Inc., Chicago, IL, USA). P < 0.05 was
considered to be statistically significant.
3. Results
Mean age (years) and body mass index (BMI) (kg/m2)
of the fertile and their age-matched infertile subjects are
summarized in Table 1, which clearly shows that mean age
and BMI did not differ significantly between the fertile and
all of the infertile groups.
Subjects included in the study had normal seminal
viscosity.
The seminal parameters of both groups are presented
in Table 2. No significant difference (P > 0.05) was found
between the semen pH, liquefaction time (minutes),
and semen volume (mL) of the fertile and all of the
infertile groups. Sperm concentration was observed to be
significantly lower (P < 0.001) in all of the infertile groups
except the normozoospermic group (P > 0.05) as compared
to the fertile group (Table 2). Sperm vitality was observed to
be significantly lower (P < 0.001) in the asthenozoospermic,

asthenoteratozoospermic, oligoasthenozoospermic, and
oligoasthenoteratozoospermic groups as compared
to the fertile group, while no significant difference (P
> 0.05) was observed between the oligozoospermic,
normozoospermic, and fertile groups (Table 2). Similarly,
total sperm motility and progressive sperm motility were
observed to be significantly lower (P < 0.05) in all of the
infertile groups except the oligozoospermic group (P >
0.05) as compared to the fertile group, as shown in Table 2.
Further morphological examinations revealed
that normal sperm forms were significantly lower (P <
0.001) in all of the infertile groups relative to those of
the fertile group as depicted in Table 2. Malformations
of the head and midpiece were significantly higher in
all of the infertile groups except the oligozoospermic
group relative to the fertile males. Tail defects showed
no significant difference between the fertile and all of the
infertile groups (Table 2).
We assessed sperm DNA fragmentation between
infertile and fertile subjects by using a comet assay. Sperm
DNA fragmentation (SDF) is graphed in the Figure, which
clearly shows that SDF (%) was significantly higher (P <
0.001) in all of the infertile males as compared to the fertile
males.
Reproductive hormone levels are summarized in Table
3. FSH levels (mIU/mL) were found to be significantly
lower (P < 0.001) in the infertile normozoospermic and
asthenozoospermic groups as compared to the fertile
group, while no significant difference (P > 0.05) was
observed between the other infertile groups as compared
to the fertile group. On the other hand, significantly lower
serum LH (mIU/mL) and testosterone (ng/mL) levels were
observed in all of the infertile (P < 0.05) groups compared
to the fertile group.
4. Discussion
Semen analysis is the most useful and basic investigation
in the search for the cause of male infertility. It provides
insight into not only sperm production (count) but also

Table 1. Mean age (years) and BMI (kg/m2) of the fertile and infertile normozoospermic (NZ), azoospermic (AZO), asthenozoospermic
(AZ), asthenoteratozoospermic (ATZ), oligozoospermic (OZ), oligoasthenozoospermic (OAZ), and oligoasthenoteratozoospermic
(OATZ) males.

Parameter

Fertile
(n = 26)

Age (years)
BMI (kg/m2)

Infertile (n = 154)
NZ
(n = 58)

AZO
(n = 20)

AZ
(n = 22)

ATZ
(n = 9)

OZ
(n = 7)

OAZ
(n = 12)

OATZ
(n = 26)

33.23 ± 5.81

30.24 ± 5.74NS

33.89 ± 6.51NS

31.64 ± 5.69NS

27.75 ± 5.53NS

32.87 ± 5.85NS

31 ± 4.97NS

31.08 ± 6.25NS

24.98 ± 3.31

23.36 ± 2.72NS

23.52 ± 4.43NS

25.32 ± 2.83NS

24.14 ± 2.58NS

24.77 ± 3.57NS

24.06 ± 3.72NS

24.58 ± 4.77NS

Values = mean ± SD and NS =statistically nonsignificant as compared to the fertile group.
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7.6 ± 0.32

24.4 ± 5.48

3.16 ± 1.11

71 ± 22.73

81.1 ± 7.39

73.9 ± 8.06

64.8 ± 6.72

77.5 ± 9.84

11.1 ± 5.58

7.31 ± 3.78

4.15 ± 3.73

Semen pH

Semen liq. time (min)

Semen vol. (mL)

Sperm conc. (×106/mL)

Sperm vitality (%)

T. sperm mot. (%)

Prog. mot. (%)

Normal form (%)

Abnormal head (%)

Abnorm. midpiece (%)

Abnormal tail (%)

6.45 ± 3.73NS

14.72 ± 8.94*

18.38 ± 6.97***

60.97 ± 15.42***

50.86 ± 12.07***

64.83 ± 13.92*

73.41 ± 9.36NS

63.96 ± 20.85NS

3.89 ± 2.42NS

23.78 ± 6.32NS

7.78 ± 0.41NS

NZ
(n = 58)

Infertile (n = 154)

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

2.83 ± 1.33NS

9.55 ± 4.06NS

30.91 ± 6.84***

29.55 ± 7.71***

28.64 ± 11.77***

14.18 ± 10.03***

28.27 ± 10.96***

32.64 ± 15.59***

47.27 ± 17.59***

4.54 ± 1.99NS

24.68 ± 5.25NS

7.74 ± 0.26NS

7.7 ± 0.39NS
24 ± 6.12NS

AZ
(n = 22)

AZO
(n = 20)

11.25 ± 5.83NS

35 ± 12.54***

38.75 ± 7.91***

2.75 ± 0.46***

17.5 ± 11.02***

32.5 ± 19.09***

36.75 ± 20.12***

32 ± 10.58***

2 ± 0.76NS

25.5 ± 5.16NS

7.67 ± 0.21NS

ATZ
(n = 9)

10 ± 4.47NS

16.67 ± 9.31NS

20 ± 0.01NS

55 ± 11.83***

53.33 ± 6.83NS

70 ± 8.94

76.67 ± 6.83NS

10.33 ± 2.25***

1.66 ± 0.52NS

25.67 ± 4.13NS

7.65 ± 0.19NS

OZ
(n = 7)

21.67 ± 15.28NS

25.83 ± 8.75***

36.67 ± 11.55***

19.17 ± 7.64***

15.83 ± 7.02***

38.33 ± 12.67***

45.5 ± 13.33***

11.92 ± 2.05***

2.41 ± 0.93NS

25.42 ± 5.88NS

7.65 ± 0.27NS

OAZ
(n = 12)

16.77 ± 19.67NS

33.23 ± 13.44***

47.85 ± 12.34***

1.31 ± 1.35***

0.54 ± 1.42***

14.38 ± 13.83***

23.85 ± 15.89***

10.38 ± 8.83***

3.22 ± 2.66NS

24.27 ± 6.58NS

7.62 ± 0.32NS

OATZ
(n = 26)

Values = mean ± SD, NS =statistically nonsignificant as compared to the fertile group, * = P < 0.05, ** = P < 0.01, and *** = P < 0.001 compared to the fertile group.
Liq = liquefaction, vol = volume, conc. = concentration, T. sperm mot. = total sperm motility, Prog. mot. = progressive motility, and Abnorm. midpiece = abnormal midpiece.

Fertile
(n = 26)

Parameter

Table 2. Seminal parameters of the fertile and infertile normozoospermic (NZ), azoospermic (AZO), asthenozoospermic (AZ), asthenoteratozoospermic (ATZ), oligozoospermic
(OZ), oligoasthenozoospermic (OAZ), and oligoasthenoteratozoospermic (OATZ) males.
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Figure. Sperm DNA fragmentation of the fertile and infertile normozoospermic (NZ), azoospermic (AZO), asthenozoospermic (AZ),
asthenoteratozoospermic (ATZ), oligozoospermic (OZ), oligoasthenozoospermic (OAZ), and oligoasthenoteratozoospermic (OATZ)
males (values expressed as mean ± SD,*** = P < 0.001 compared to the fertile group).
Table 3. Hormonal profiles of the fertile and infertile normozoospermic (NZ), azoospermic (AZO), asthenozoospermic (AZ),
asthenoteratozoospermic (ATZ), oligozoospermic (OZ), oligoasthenozoospermic (OAZ), and oligoasthenoteratozoospermic (OATZ)
males.

Parameter

Fertile
(n = 26)

FSH (mIU/mL)
LH (mIU/mL)

Infertile (n = 154)
NZ
(n = 58)

AZO
(n = 20)

AZ
(n = 22)

ATZ
(n = 9)

OZ
(n = 7)

OAZ
(n = 12)

OATZ
(n = 26)

8.17 ± 3.76

3.51 ± 3.59***

3.35 ± 2.92NS

6.68 ± 3.59***

5.01 ± 0.90NS

4.58 ± 3.79NS

5.92 ± 1.93NS

5.59 ± 3.78NS

4.22 ± 1.59

1.52 ± 1.91***

1.54 ± 2.23***

2.28 ± 1.86**

1.35 ± 0.95**

1.86 ± 2.25NS

2.20 ± 0.86*

1.56 ± 2.27***

Testosterone (ng/mL) 8.57 ± 0.82

2.34 ± 1.50***

1.99 ± 0.92***

2.82 ± 1.81***

2.62 ± 1.38***

2.60 ± 1.95***

1.43 ± 0.53***

1.70 ± 1.04***

Values = mean ± SD, NS = statistically nonsignificant as compared to the fertile group, * = P < 0.05, ** = P < 0.01, and *** = P < 0.001 compared to the
fertile group.

sperm quality (motility and morphology). More than 90%
of cases of male infertility are due to low sperm count or
poor semen quality or both.
The prevalence of normozoospermia in our study was
32.95%, azoospermia was 10.22%, asthenozoospermia
was 12.51%, asthenoteratozoospermia was 4.54%,
oligozoospermia was 3.41%, oligoasthenozoospermia was
6.81%, and oligoasthenoteratozoospermia was 14.78%.
The prevalence of oligoasthenoteratozoospermia observed
in our study is comparable to that of Jahan et al. (2011),
who observed the prevalence as 11.69% (16). The findings
of the present study are also in agreement with those of Butt
and Akram, who noted the prevalence of oligozoospermia
as 11.11%, oligoasthenoteratozoospermia as 9.09%, and
azoospermia as 14.89% (17). Similarly, the results of our
work are also in agreement with the work done by Khan et
al. They observed the prevalence of azoospermia as 14.28%
and that of oligozoospermia as 21.43% (18). However,
another study revealed the prevalence of azoospermia as
13.3%, oligozoospermia as 23.3%, normozoospermia as
14.5%, and asthenozoospermia as 35.2% in the Pakistani

population (19). The incidence of azoospermia in Pakistan
was reported as 12.32% and 16% in two separate studies,
which is comparable to our study (20,21). In connection
with that, the incidence of azoospermia in the Pakistani
population is comparable to the USA and Kenya, with
reported rates of 10% and 11.35% respectively (22,23).
Age and BMI are other parameters that affect the
fertility of patients. In this study, age and BMI of the fertile
and infertile subjects revealed no significant difference.
This can be compared with similar studies of both
Pakistani subjects in different cities (16) and other studies
from around the world (24,25).
Alterations in seminal pH may reflect an abnormality
in the functioning of the accessory sex glands or
ejaculatory duct obstruction. The present study revealed
no significant difference in the mean seminal pH of the
fertile and infertile subjects (Table 2). Studies conducted
on seminal pH levels in the USA (26), Norway (27), and
in the Pakistani population (19) also expressed similar
results. Similarly, in the present study, the mean semen
liquefaction time of the fertile and infertile subjects
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showed no significant difference. Semen liquefaction
time was noted as normal in all subjects (Table 2) and is
comparable to the results of other studies conducted in
China (28) and Pakistan (18,19).
Low semen volumes may reflect an abnormality in
the functioning of the accessory sex glands. The mean
semen volumes of the infertile and fertile subjects showed
no significant difference (Table 2). The majority of the
subjects participating in this study had a normal semen
volume and this result is in agreement with the studies
conducted in different parts of Pakistan (17–19) and the
world (24,25,29–31). The adequate volume of ejaculated
semen obtained in our study may be due to the 3–7 days of
sexual abstinence prior to sample collection.
Sperm concentration in the ejaculate reflects the activity
and functioning of the gonads in males and the patency
of the posttesticular duct system. Studies have revealed
that the pregnancy rates in couples decline as sperm
concentrations decrease (32,33). Sperm concentration in
the present study is outlined in Table 2 and was observed
to be significantly lower in all of the infertile groups except
the normozoospermic group as compared to the fertile
group. Other studies in Pakistan have revealed similar
results of sperm concentration in infertile men (17–19).
The results are also comparable to those of a similar study
by Mortimer et al., with a mean sperm density of 84.3 ±
78.3 (34).
Vitality assessment is essential to differentiate dead
sperm from immotile spermatozoa. Sperm vitality is
summarized in Table 2 and it was significantly lower in
all of the infertile groups except the oligozoospermic and
normozoospermic groups as compared to the fertile group.
The results of a similar study conducted on Chinese men
revealed sperm viability to be 73.8% in healthy Chinese
men, which is comparable to the present study (35).
Sperm motility is essential for the sperm to pass
through the cervical mucus plug in order to fertilize the
ovum. Total sperm motility and progressive sperm motility
are summarized in Table 2 and were observed to be
significantly lower in all of the infertile groups except the
oligozoospermic group as compared to the fertile group.
Similar results for sperm motility in fertile and infertile
groups were also shown in other studies of the Pakistani
population (17–19,21). A similar study conducted
on the Pakistani population showed a prevalence of
asthenozoospermia as 25% (17); however, a study
conducted at the NIH in Islamabad, Pakistan expressed
the prevalence as 21.42% (19). Yet another study observed
the prevalence of asthenozoospermia as 18% (18). The
mean sperm motility of the fertile, normozoospermic, and
oligozoospermic subjects in our study is similar to those
of other studies conducted on fertile men (24,25,29,35,36).
Normal sperm morphology, i.e. the differential
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development of the head, midpiece, and tail of a mature
spermatozoon from the spermatid and spermatocytes, is
a function of the testes as well as the epididymis. Normal
sperm forms are outlined in Table 2 and were significantly
lower in all of the infertile groups as compared to the fertile
group. The results of our study are comparable to those of
another study that showed mean normal morphology in
normozoospermia samples as 65 ± 14% compared to 45
± 15.65% in oligozoospermic samples (17). Furthermore,
abnormal sperm morphology has been observed in 53%
of oligozoospermic males and abnormal motility has been
observed in 60% of oligozoospermic males (18). A similar
pattern of abnormal sperm forms in different infertile and
fertile groups was also shown by a study conducted at the
NIH in Islamabad, Pakistan (19).
Sperm DNA damage is not currently included in routine
clinical investigations of infertility. Investigation of sperm
DNA damage has been demonstrated as a promising tool
in determining a male patient’s fertility status as well as
the outcomes following assisted reproduction treatment.
Many techniques have been described to detect the status
of sperm DNA damage, such as the sperm chromatin
structure assay (SCSA), sperm chromatin dispersion
test (SCD), DNA breakage detection–fluorescent in situ
hybridization (DBD–FISH) assay, deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL)
test, in situ nick translation, comet assay, and the
measurement of 8–hydroxyl–2–deoxyguanosine (8OHdG) by high performance liquid chromatography
(HPLC) (37). However, little data are available to make a
comparison of these methods. According to researchers
(37–41), amongst the methods currently available to
evaluate sperm DNA damage status, the comet assay is
considered to be the most sensitive and reliable (38,41). It
is the only technique that allows quantitative assessment
of DNA damage in individual cells and so it is particularly
useful in heterogeneous cell populations like spermatozoa.
The comet assay measures single- and double-strand
breaks as well as abasic sites (41). In addition, it requires
only a small number of cells, making it suitable to evaluate
DNA damage in semen samples (42). It has also been
demonstrated to provide a stronger prognostic ability to
predict fertilization after IVF than progressive motility
(43).
The DNA integrity of sperm is essential for the accurate
transmission of genetic information, and therefore the
maintenance of good health of future generations. DNA
damage in sperm may carry mutations into the next
generation or may result in male infertility (44). Moreover,
a compromised DNA integrity of sperm has been linked
to failed fertilization (45). Sperm DNA fragmentation is
depicted in the Figure and was observed to be significantly
elevated in all of the infertile groups as compared to the
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fertile group, indicating that subjects that had low semen
quality also had higher levels of DNA damage. Sperm
DNA damage was significantly increased in infertile
patients suffering from varicocele (n = 32) as compared
to the fertile ones and could have been due to increased
exposure to reactive oxygen species (46–49). The sperm
DNA damage in the infertile normozoospermic group
with normal sperm parameters and the oligozoospermic
group was significantly higher than that for the fertile
subjects but not significantly different from that of the
other infertile subgroups. It is now clear that many men
with normal seminal parameters have elevated levels of
sperm DNA damage. Increased sperm DNA damage may
be responsible for the low fertility in men who otherwise
have normal standard seminal parameters on repeated
analysis and are diagnosed as unexplained or idiopathic.
The mechanism(s) underlying the increased sperm DNA
damage in normozoospermic males could be an inherent
defect in the sperm chromatin packing or the damage
could occur after spermeation (46,47). Similar results
were noted in studies conducted in Scotland (38), Spain
(15), and Canada (50) that revealed the impaired semen
quality observed in the infertile group was associated with
a significantly increased rate of DNA damage as compared
to the fertile group. Similar results were also shared in the
studies conducted by Benchaib (51) and Morris (10).
The reproductive hormonal measurements of the
present study revealed that serum LH and testosterone
levels were significantly lower in all of the infertile groups
than in the fertile group, while FSH was significantly
lower in the normozoospermic and asthenozoospermic

groups as compared to the fertile group but did not differ
significantly between the other infertile groups and the
fertile males, as shown in Table 3. It has been previously
reported that the serum levels of both LH and FSH are
higher (52–54), lower (55), or unmodified (56) in infertile
and azoospermic males as compared to normal males.
On the other hand, no such change was observed in the
FSH serum level in oligozoospermic males relative to that
of fertile ones (57,58). It has been shown that high levels
of intratesticular testosterone secreted by the Leydig cells
are necessary for spermatogenesis. Inside the Sertoli cells,
testosterone selectively binds to the androgen receptor and
leads to the activation and maintenance of spermatogenesis
while the action of FSH minimally serves to promote
spermatogenic output by increasing the number of Sertoli
cells (59,60).
The study revealed that the seminal parameters in all
of the infertile groups were lower than those for the fertile
group. The sperm DNA fragmentation was higher in all of
the infertile subjects as compared to the fertile ones and
showed a negative correlation with the seminal parameters,
i.e. the sperm DNA damage increases with lower levels of
semen quality. The levels of reproductive hormones were
also reduced in infertile males.
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